24 research outputs found
Hepatobiliary phenotypes of adults with alpha-1 antitrypsin deficiency
OBJECTIVE: Alpha-1 antitrypsin deficiency (AATD) is a common, potentially lethal inborn disorder caused by mutations in alpha-1 antitrypsin (AAT). Homozygosity for the 'Pi*Z' variant of AAT (Pi*ZZ genotype) causes lung and liver disease, whereas heterozygous 'Pi*Z' carriage (Pi*MZ genotype) predisposes to gallstones and liver fibrosis. The clinical significance of the more common 'Pi*S' variant remains largely undefined and no robust data exist on the prevalence of liver tumours in AATD. DESIGN: Baseline phenotypes of AATD individuals and non-carriers were analysed in 482â380 participants in the UK Biobank. 1104 participants of a multinational cohort (586 Pi*ZZ, 239 Pi*SZ, 279 non-carriers) underwent a comprehensive clinical assessment. Associations were adjusted for age, sex, body mass index, diabetes and alcohol consumption. RESULTS: Among UK Biobank participants, Pi*ZZ individuals displayed the highest liver enzyme values, the highest occurrence of liver fibrosis/cirrhosis (adjusted OR (aOR)=21.7 (8.8-53.7)) and primary liver cancer (aOR=44.5 (10.8-183.6)). Subjects with Pi*MZ genotype had slightly elevated liver enzymes and moderately increased odds for liver fibrosis/cirrhosis (aOR=1.7 (1.2-2.2)) and cholelithiasis (aOR=1.3 (1.2-1.4)). Individuals with homozygous Pi*S mutation (Pi*SS genotype) harboured minimally elevated alanine aminotransferase values, but no other hepatobiliary abnormalities. Pi*SZ participants displayed higher liver enzymes, more frequent liver fibrosis/cirrhosis (aOR=3.1 (1.1-8.2)) and primary liver cancer (aOR=6.6 (1.6-26.9)). The higher fibrosis burden was confirmed in a multinational cohort. Male sex, age â„50âyears, obesity and the presence of diabetes were associated with significant liver fibrosis. CONCLUSION: Our study defines the hepatobiliary phenotype of individuals with the most relevant AATD genotypes including their predisposition to liver tumours, thereby allowing evidence-based advice and individualised hepatological surveillance
Stingless bee honey protects against lipopolysaccharide induced-chronic subclinical systemic inflammation and oxidative stress by modulating Nrf2, NF-ÎșB and p38 MAPK
Background: Epidemiological and experimental studies have extensively indicated that chronic subclinical systemic inflammation (CSSI) and oxidative stress are risk factors for several chronic diseases, including cancer, arthritis, type 2 diabetes, and cardiovascular and neurodegenerative diseases. This study examined the protective effect of stingless bee honey (SBH) supplementation against lipopolysaccharide (LPS)-induced CSSI, pointing to the possible involvement of NF-ÎșB, p38 MAPK and Nrf2 signaling. Methods: CSSI was induced in male Sprague Dawley rats by intraperitoneal injection of LPS three times per week for 28âdays, and SBH (4.6 and 9.3âg/kg/day) was supplemented for 30âdays. Results: LPS-induced rats showed significant leukocytosis, and elevated serum levels of CRP, TNF-α, IL-1ÎČ, IL-6, IL-8, MCP-1, malondialdehyde (MDA) and 8-hydroxy-2âČ-deoxyguanosine (8-OHdG), accompanied with diminished antioxidants. Treatment with SBH significantly ameliorated inflammatory markers, MDA and 8-OHdG, and enhanced antioxidants in LPS-induced rats. In addition, SBH decreased NF-ÎșB p65 and p38 MAPK, and increased Nrf2 expression in the liver, kidney, heart and lung of LPS-induced rats. Furthermore, SBH prevented LPS-induced histological and functional alterations in the liver, kidney, heart and lung of rats. Conclusion: SBH has a substantial protective role against LPS-induced CSSI in rats mediated via amelioration of inflammation, oxidative stress and NF-ÎșB, p38 MAPK and Nrf2 signaling
The cxcr4 antagonist pol5551 is equally effective as sirolimus in reducing neointima formation after arterial injury without impairing re-endothelialisation
Standard Operating Procedures in Experimental Liver Research : thioacetamide model in mice and rats
Simultaneous non-invasive assessment of liver injury and body composition in alpha1-antitrypsin deficiency
Transferrin gene ChIP-seq data
ChIP-seq Peak-calling data to support the supplementary information to:
In severe alcoholic hepatitis, serum transferrin constitutes an independent mortality predictor indicating an impaired HNF4αsignaling. Stephen R. Atkinson, MD*; Karim Hamesch, MD*; Igor Spivak, MD; Nurdan Guldiken, PhD; JoaquĂn Cabezas, PhD3; Josepmaria Argemi, PhD; Igor Theurl, MD, Heinz Zoller, MD; Sheng Cao, MD; Philippe Mathurin, MD; Vijay H. Shah, MD; Christian Trautwein, MD; Ramon Bataller, MD; Mark R. Thursz, MD+; Pavel Strnad, MD+ChIP-seq Peak-calling data to support the supplementary information to: In severe alcoholic hepatitis, serum transferrin constitutes an independent mortality predictor indicating an impaired HNF4αsignaling. Stephen R. Atkinson, MD*; Karim Hamesch, MD*; Igor Spivak, MD; Nurdan Guldiken, PhD; JoaquĂn Cabezas, PhD3; Josepmaria Argemi, PhD; Igor Theurl, MD, Heinz Zoller, MD; Sheng Cao, MD; Philippe Mathurin, MD; Vijay H. Shah, MD; Christian Trautwein, MD; Ramon Bataller, MD; Mark R. Thursz, MD+; Pavel Strnad, MD
Serum Perilipin 2 (PLIN2) Predicts Multiple Organ Dysfunction in Critically Ill Patients
Perilipin 2 (PLIN2) is a lipid droplet protein with various metabolic functions. However, studies investigating PLIN2 in the context of inflammation, especially in systemic and acute inflammation, are lacking. Hence, we assessed the relevance of serum PLIN2 in critically ill patients. We measured serum PLIN2 serum in 259 critically ill patients (166 with sepsis) upon admission to a medical intensive care unit (ICU) compared to 12 healthy controls. A subset of 36 patients underwent computed tomography to quantify body composition. Compared to controls, serum PLIN2 concentrations were elevated in critically ill patients at ICU admission. Interestingly, PLIN2 independently indicated multiple organ dysfunction (MOD), defined as a SOFA score > 9 points, at ICU admission, and was also able to independently predict MOD after 48 h. Moreover, serum PLIN2 levels were associated with severe respiratory failure potentially reflecting a moribund state. However, PLIN2 was neither a predictor of ICU mortality nor did it reflect metabolic dysregulation. Conclusively, the first study assessing serum PLIN2 in critical illness proved that it may assist in risk stratification because it is capable of independently indicating MOD at admission and predicting MOD 48 h after PLIN2 measurement. Further evaluation regarding the underlying mechanisms is warranted